Research Bowel disease IBD
Investigative use of cannabidiol in sublingual preparation for Crohns' disease and Ulcerative Colitis.
Crohn’s disease is an inflammatory bowel disease (IBD). It causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhoea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people.
The inflammation caused by Crohn’s disease often spreads deep into the layers of affected bowel tissue. Crohn’s disease can be both painful and debilitating, and sometimes may lead to life-threatening complications.
While there’s no known cure for Crohn’s disease, therapies can greatly reduce its signs and symptoms and even bring about long-term remission. With treatment, many people with Crohn’s disease are able to function well.
Large numbers of patients worldwide are taking cannabinoid-based preparations for inflammatory bowel disease of various types.
Our aim in this arm of the research is to capture patients with self-reported conditions, currently on no or standard therapy, and see whether cannabidiol provides a safe extension to the period of remission:
- Inflammatory Bowel Disease
- Chronic Inflammatory Bowel
- Leaky Gut Syndrome
- Ulcerative colitis
- Chronic Diarrhoea
- Chronic mouth ulceration